Health care bill burns local tanning industry
With one of the nation’s largest tanning-bed manufacturers and dozens of salons in central Indiana, a 10-percent tax on tanning
could cost the region jobs.
Cancer
Articles
IU cancer center names new director
Dr. Patrick J. Loehrer Sr. replaces Dr. Stephen D. Williams, the center’s founding director, who died of cancer in February
2009.
House approves smoking ban in public places
The House has approved legislation that would ban smoking in public places statewide except casinos and pari-mutuel horse
racing venues.
Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe
New Jersey-based Enzon Pharmaceuticals Inc. has sold its Indianapolis plant that manufactures specialty drugs in a deal that
could top $300 million. The buyer says that the operations, which employ about 100, will remain in the city.
HICKS: New breast cancer recommendation not supported
Under the current proposal, the same type of groups that made the CDC’s recommendations will outline guidelines about which treatment will be offered under a government program.
Indy Chamber of Commerce endorses smoking ban
The Indianapolis Chamber of Commerce is throwing its weight behind a tougher workplace smoking ban up for consideration tonight
by the City-County Council.
Lilly, GE announce cancer diagnostic breakthrough
Eli Lilly and Co. and General Electric Co. say they’ve made a breakthrough in cancer research that could help Lilly cut the size and cost of its clinical trials.
Endocyte receives $26M infusion from investors
West Lafayette-based Endocyte Inc. announced Friday that it has closed on $26 million in equity financing to help the company
continue developing cancer-fighting drugs.
Lilly: Alimta improves lung-cancer survival time
Indianapolis-based Eli Lilly and Co. announced today that a clinical trial showed lung cancer patients treated with Lilly
drug Alimta lived about three months longer than those who received the best available care.
DAVIS: Looming deadline not so big now
The exact words the doctor used that day are forever lost in a blur of
hospital gowns and ultrasound gel and post-biopsy instructions.
Endocyte, Purdue develop prostate cancer treatment device
Purdue University researcher Philip Low, also the chief science officer for West Lafayette-based Endocyte Inc., has developed
a prostate cancer “homing device” to help anti-cancer agents specifically target prostate
cancer tumors.
Cook splits device unit to focus on cancer products
Cook Medical has split its interventional devices business into two units, pulling its lesser known cancer products out from under the shadow of its heart products.
Lilly buys ImClone as part of strategy to capitalize on cancer-drug market
Eli Lilly and Co. has written a $6.5 billion IOU to acquire the cancer drugs of ImClone Systems Inc. Cancer drugs are now
the best-selling class of drugs in the world and one of the fastest growing.